PT91293A - Processo para a preparacao de composicoes farmaceuticas com actividade imunossupressiva, contendo 4-imino-1,3-diazabiciclo -(3.1.0)-hexano-2-ona - Google Patents

Processo para a preparacao de composicoes farmaceuticas com actividade imunossupressiva, contendo 4-imino-1,3-diazabiciclo -(3.1.0)-hexano-2-ona

Info

Publication number
PT91293A
PT91293A PT198991293A PT9129389A PT91293A PT 91293 A PT91293 A PT 91293A PT 198991293 A PT198991293 A PT 198991293A PT 9129389 A PT9129389 A PT 9129389A PT 91293 A PT91293 A PT 91293A
Authority
PT
Portugal
Prior art keywords
diazabicyclo
imino
hexano
ona
preparation
Prior art date
Application number
PT198991293A
Other languages
English (en)
Other versions
PT91293B (pt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PT91293A publication Critical patent/PT91293A/pt
Publication of PT91293B publication Critical patent/PT91293B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Prostheses (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT91293A 1988-07-28 1989-07-27 Processo para a preparacao de composicoes farmaceuticas com actividade imunossupressiva, contendo 4-imino-1,3-diazabiciclo -(3.1.0)-hexano-2-ona PT91293B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3825667A DE3825667A1 (de) 1988-07-28 1988-07-28 Verwendung von imexon als immunsuppressivum

Publications (2)

Publication Number Publication Date
PT91293A true PT91293A (pt) 1990-02-08
PT91293B PT91293B (pt) 1995-03-01

Family

ID=6359767

Family Applications (1)

Application Number Title Priority Date Filing Date
PT91293A PT91293B (pt) 1988-07-28 1989-07-27 Processo para a preparacao de composicoes farmaceuticas com actividade imunossupressiva, contendo 4-imino-1,3-diazabiciclo -(3.1.0)-hexano-2-ona

Country Status (14)

Country Link
EP (1) EP0352652B1 (pt)
JP (1) JP2848634B2 (pt)
KR (1) KR0135757B1 (pt)
AT (1) ATE117551T1 (pt)
AU (1) AU619027B2 (pt)
CA (1) CA1333771C (pt)
DE (2) DE3825667A1 (pt)
DK (1) DK175199B1 (pt)
HU (1) HU206827B (pt)
IE (1) IE66680B1 (pt)
IL (1) IL91138A (pt)
PH (1) PH26684A (pt)
PT (1) PT91293B (pt)
ZA (1) ZA895710B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007513202A (ja) * 2003-12-08 2007-05-24 ジ・アリゾナ・ボード・オブ・リージェンツ・オン・ビハーフ・オブ・ザ・ユニバーシティー・オブ・アリゾナ 相乗的な抗癌組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2528460A1 (de) * 1975-06-26 1977-01-13 Boehringer Mannheim Gmbh Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans
DE2530398A1 (de) * 1975-07-08 1977-01-27 Boehringer Mannheim Gmbh Organische verbindung
DE2736296A1 (de) * 1977-08-12 1979-02-22 Boehringer Mannheim Gmbh Verwendung von 2-cyan-aziridin und seinen derivaten zur immunstimulierung

Also Published As

Publication number Publication date
PH26684A (en) 1992-09-15
ATE117551T1 (de) 1995-02-15
AU619027B2 (en) 1992-01-16
DE3825667C2 (pt) 1991-06-27
DE3825667A1 (de) 1990-03-15
EP0352652A2 (de) 1990-01-31
CA1333771C (en) 1995-01-03
DK363389D0 (da) 1989-07-21
IL91138A (en) 1994-10-21
DK175199B1 (da) 2004-07-05
ZA895710B (en) 1990-04-25
AU3887789A (en) 1990-02-01
PT91293B (pt) 1995-03-01
HUT52378A (en) 1990-07-28
JPH0288521A (ja) 1990-03-28
IE66680B1 (en) 1996-01-24
EP0352652A3 (de) 1991-09-04
EP0352652B1 (de) 1995-01-25
JP2848634B2 (ja) 1999-01-20
IL91138A0 (en) 1990-03-19
HU206827B (en) 1993-01-28
IE892448L (en) 1990-01-28
DE58908926D1 (de) 1995-03-09
KR900001369A (ko) 1990-02-27
KR0135757B1 (ko) 1998-04-23
DK363389A (da) 1990-01-29

Similar Documents

Publication Publication Date Title
KR960701049A (ko) 헤테로사이클릭 화합물, 이의 제조방법 및 이의 용도(Heterocyclic compounds and their preparation and use)
PT85055A (pt) Processo para a preparacao de composicoes farmaceuticas contendo ester metilico da levodopa
PT98734A (pt) Processo de preparacao de compostos 1,2,5,6-tetra-hidropiridina e de composicoes farmaceuticas que os contem
FI954131A (fi) Heterosykliset yhdisteet ja niiden valmistus ja käyttö
PT98736A (pt) Processo de preparacao de compostos de piperidina e de composicoes farmaceuticas que os contem
PT98735A (pt) Processo de preparacao de compostos azaciclicos e de composicoes farmaceuticas que os contem
IL104261A (en) Azacyclic and azabicyclic compounds, their preparation and pharmaceutical compositions comprising them
DE69021724D1 (de) Modifizierte Protease, Verfahren zu deren Herstellung und diese enthaltende kosmetische Zusammensetzungen.
MY106231A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2- thiones.
CA2063416A1 (en) Methods of treating or preventing autoimmune uveoretinitis mammals
PT91293A (pt) Processo para a preparacao de composicoes farmaceuticas com actividade imunossupressiva, contendo 4-imino-1,3-diazabiciclo -(3.1.0)-hexano-2-ona
EP0378413A3 (en) Compositions for topical treatment of skin disorders
NO902934L (no) Fremgangsmaate for fremstilling av 4h-indolo(1,2-d)(1,2,4)-triazolo(4,3-a)(1,4)benzodiazepiner, samt anvendelse som medikamenter.
FR2625507B1 (fr) Procede de preparation d'un copolymere de deux acides (alpha)-amines et copolymere ainsi obtenu
FI102065B1 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia 2-amino-4-morfolino-6-propyyli-1,3,5-triatsiineja
ATE137752T1 (de) 5-aminocarbonyl-5h-dibenzo-a,d>cyclohepten-5,10 imine zur behandlung von epilepsie und kokainsucht
MY106961A (en) Antiviral tetrahydroimidazo[1,4] benzodiazepines
EP0285883A3 (en) Bactobolin as a prophylactic or therapeutic agent for autoimmune diseases, and as an immuno-suppressive agent
ATE124409T1 (de) Azacyclische oder azabicyclische verbindungen, ihre darstellung und anwendung.
KR930700109A (ko) 신경 질환 치료용 4,4'-[9h-플루오렌-9-일리덴비스(메틸렌)]-비스피리미딘
ATE70059T1 (de) Isoxazolderivate zur verwendung als zerebralaktive wirkstoffe und zentralmuskelrelaxantien.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940818

PC3A Transfer or assignment

Free format text: AUTOONCONA PHARMA GMBH DE

Effective date: 20030630

PD3A Change of proprietorship

Free format text: ROCHE DIAGNOSTICS GMBH DE

Effective date: 20030630

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20080218